NCT02835079View on ClinicalTrials.gov

Treatment Effect of Tamoxifen on Patients With DMD

PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG

Tamoxifen

All Listed Sponsors

lead

Hadassah Medical Organization

OTHER

NCT02835079 - Treatment Effect of Tamoxifen on Patients With DMD | Biotech Hunter | Biotech Hunter